Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CD3 antigen is a multimeric cell-surface complex found exclusively on T cells, composed of four invariant polypeptide chains—gamma (γ), delta (δ), epsilon (ε), and zeta (ζ)—that associate as three dimers (γε, δε, ζζ)[7][2]. CD3 is non-covalently bound to the T-cell receptor (TCR) and is critical for intracellular signaling upon antigen recognition. Its cytoplasmic tails contain immunoreceptor tyrosine-based activation motifs (ITAMs) that serve as docking and activation sites for kinases following TCR engagement, allowing T cell activation, proliferation, and cytokine release[2][1][7]. CD3 is a therapeutic target in immunology, with monoclonal antibodies and bispecific agents (such as blinatumomab) leveraging CD3 to redirect or suppress T cell activity in cancer, autoimmune diseases, and transplantation medicine[7][5]. CD3 expression is also used as a pan-T cell marker in laboratory diagnostics[7].\nThe original query refers to cytotoxicity mediated by CD3-positive cells—these are typically CD8+ cytotoxic T lymphocytes, but the molecular target is **CD3**, not the functional phenotype.
Antibody or biologic binding to CD3 triggers T cell activation and cytotoxicity, sometimes redirecting T cells against tumor or target cells\nCan induce depletion or modulation of T cells (immunosuppression)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD3 antigen (cluster of differentiation 3) (CD3).